Award
NIH Reporter #7R21AI180902-03
Development of Antibiotic Adjuvants to Avert Resistance Conferred by Cfr, a Radical S-Adenosylmethionine Methylase
Recipient
National Institute of Allergy and Infectious Diseases (NIAID)
Award Amount
$134,523.00
Ceiling
$134,523.00
Awarded
June 11, 2026
Identifier
7R21AI180902-03
NIH awarded a grant to develop antibiotic adjuvants targeting resistance mechanisms conferred by the Cfr methylase enzyme.
Description
This is a grant project funded by NIH, focusing on developing inhibitors for bacterial resistance mechanisms. No specific bid or response instructions are provided.